Alembic receives tentative U.S.FDA approval for dronedarone tablets
Dronedarone tablets USP, 400 mg have an estimated market size of US $ 500 million for twelve months ending September 2021 according to IQVIA
Dronedarone tablets USP, 400 mg have an estimated market size of US $ 500 million for twelve months ending September 2021 according to IQVIA
A preview on Q3FY22 by Nirmal Bang Securities on select Indian pharma companies
Entacapone tablets USP, 200 mg have an estimated market size of US$ 10.5 million for twelve months ending September 2021, according to IQVIA
Doxycycline Hyclate Delayed Release tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria
The company is focused on the development of novel treatments for RNA viruses
The tablets are indicated for the treatment of pulmonary arterial hypertension
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
The ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies
Dabigatran Etexilate capsules are indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, and for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE)
The cream has an estimated market size of US $ 28 million for twelve months ending Jun 2021 according to IQVIA
Subscribe To Our Newsletter & Stay Updated